This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Sanofi Biotechnology, Sanofi-Aventis Biotechnology. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Emanuele De Rinaldis: Innovator in Eye-Related Disorders
Introduction
Emanuele De Rinaldis is a notable inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of eye-related disorders. With a total of two patents to her name, her work has the potential to impact many lives.
Latest Patents
Emanuele's latest patents include a method of treating an eye-related disorder by administering an anti-interleukin-4 receptor alpha (anti-IL-4Rα) antibody. This patent discloses methods for treating various disorders using anti-IL-4Rα antibodies and their fragments. Another significant patent focuses on methods for treating digitally identified IL-4/IL-13-related disorders by administering an anti-IL-4Rα antibody, also detailing various treatment methods with these antibodies.
Career Highlights
Throughout her career, Emanuele has worked with prominent companies in the biotechnology sector, including Sanofi-Aventis Biotechnology and Sanofi Biotechnology. Her experience in these organizations has allowed her to develop innovative solutions for complex medical issues.
Collaborations
Emanuele has collaborated with several professionals in her field, including Paul Bryce and Ramon Antonio Hernandez Vecino. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Emanuele De Rinaldis is a pioneering inventor whose work in treating eye-related disorders showcases her dedication to improving healthcare. Her patents and collaborations reflect her commitment to innovation in biotechnology.